Forget Crispr Therapeutics: This Gene-Editing Pick Attracts
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
A concise guide to planning Social Security timing from a 30s perspective, covering factors that affect when to start and how it influences lifetime benefits.
20,404 articlesThe gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Investors are asking what's going with Uber stock as the company diversifies beyond ridesharing. This guide breaks do...
A Nvidia-backed push into AI infrastructure sent Marvell Technology higher, highlighting how AI-focused hardware may ...
Micron Technology surged to a fresh all-time high after a blockbuster earnings report and strong AI-driven demand. Th...
A near-40 couple carries $86,000 in debt as they earn $200,000 a year and wonder if they should invest now or pay dow...
Peloton has faced a brutal selloff, but the story isn’t finished. This article dives into whether Peloton is broken o...
Mega IPOs attract huge attention, but history teaches a sober lesson about valuation, timing, and long-term returns. ...
A practical look at a top energy stock evolving at the crossroads of renewables and AI. Learn how to assess the setup...
Hims Hers Health shares jumped after news of a Novo Nordisk collaboration. This guide breaks down what the deal could...
Zebra Technologies stock jumped sharply this morning after a solid Q1 2026 report. This article breaks down the numbe...
When a top executive sells stock, investors ask: Is this a red flag or routine planning? This guide breaks down the 9...
A wave of zoning changes could unlock dense housing in cities across the U.S. This article explains how sweeping zoni...